Sun Pharma inks exclusive pact with Philogen for commercializing anti-cancer drug Fibromun
Sun Pharmaceutical Industries said that it has entered into a global exclusive commercialization, license, and supply agreement with Philogen for commercializing the latter's specialty product Fibromun.